JNJ
2025Q4BMOJohnson & Johnson primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS2.46
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move1.2%
IV front—
P/C full—
P/C front—
Features as of2026-01-20
Run-up
Close—
Ret 5d+4.0%
Ret 10d+6.8%
Ret 20d+4.8%
Ret 30d+7.8%
Actual EPS
2.46—
Estimated EPS2.46
Actual revenue
24.6B
Surprise %0.0%
Beat / miss—
Beat streak 40
Beat streak 80
Reaction
1-day stock reaction+3.3%
Implied vs actual
Implied 1.2%Actual 3.3%
Gap reaction-3.3%
Day result-0.1%
Next-day upYes
Realized / IV2.75×
Post tape
Post 5d+4.5%
Post 10d+7.6%
Post volume14.8M
Vol ×10d1.54×
Vol ×20d1.75×
Post range3.9%